Influenza

CDC has released mid-season estimates indicating approximately 84,000 Americans have been hospitalized for the influenza so far this season.

A new method assessing the influenza A strain provides investigators with a more detailed look at influenza viruses.

In 2017, lower respiratory tract infections linked with influenza were responsible for an estimated 145,000 deaths worldwide.

Updated guidelines will hopefully spur more clinicians to test for and treat influenza in people with symptoms whether they’re high risk or not.

With early season flu vaccination rates up from 2017-2018 early season rates, new pediatric influenza deaths around the country are prompting health officials to call for even higher vaccination rates.

Concerns over the influenza vaccine’s effectiveness and its side effects are causing many Americans to forego an influenza vaccine this season, despite the severity of the 2017-2018 Season.

People living with HIV should get a flu shot each year, according to experts.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A new survey has found that 34% of US parents are not planning to have their child vaccinated against influenza.

A new study explores the concept of an epidemic calendar, with new findings suggesting that all infectious disease outbreaks have a seasonal element.

The results of a new study suggest these immune-system organs may be more involved in the disease than originally thought.

A new study sheds light onto showerheads as a source for mycobacterial infections.

Investigators have found that children who received a flu shot in consecutive years did not see a decline in vaccine effectiveness.

Investigators have found the quadrivalent vaccination to be as effective as trivalent standard-dose, while the high-dose trivalent was found to be more effective than the trivalent standard-dose.

Keeping communities safe from potentially deadly viruses is everyone’s responsibility.

New outbreaks of rubella and troubling data on influenza highlight the importance of vaccination.

The results of a new study suggest that a high-dose trivalent influenza vaccine recommended for older adults may also benefit patients with kidney disease who are on dialysis.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The assays are supported by the ID NOW platform with an instrument-based isothermal system for the qualitative detection of infectious diseases.

Mike Ison, MD, MS, discusses the key takeaways from the CAPSTONE-2 phase 3 trial evaluating baloxavir marboxil for the treatment of patients with influenza.

Today, the US Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

The phase 3 CAPSTONE-2 trial shows treatment with baloxavir marboxil significantly reduced the time to improvement of flu symptoms compared with placebo.

The US Food and Drug Administration (FDA) has extended approval for the use of AFLURIA quadrivalent influenza vaccine in individuals 6 months and older.

As knowledge and awareness of rising antimicrobial resistance increase, clinicians must continue to adopt strategies for improving antibiotic use.

A new report on influenza vaccination rates among US health care workers finds that employer requirements help keep vaccination rates of health care workers higher than that of the general public.